Goldman Sachs has projected a notable economic upturn in the United States with the increased usage of GLP-1 weight loss medications. According to their...
Azurity Pharmaceuticals has issued a recall for the widely-used Attention Deficit Hyperactivity Disorder (ADHD) medication, Zenzedi, after a mix-up was discovered in the packaging....
Let’s talk about the pharmaceutical scene, where companies like Merck are making notable progress after the expiration of Keytruda’s patent. According to Merck’s CEO,...